{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:11:23Z","timestamp":1782159083203,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["grant no. 2014\/13\/B\/NZ5\/03146"],"award-info":[{"award-number":["grant no. 2014\/13\/B\/NZ5\/03146"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10741-018-9738-4","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T03:42:14Z","timestamp":1538538134000},"page":"269-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Structural and functional abnormalities in iron-depleted heart"],"prefix":"10.1007","volume":"24","author":[{"given":"Kamil A","family":"Kobak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malwina","family":"Radwa\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Dzi\u0119ga\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kasztura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Josiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Banasiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa A","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"9738_CR1","first-page":"164","volume":"19","author":"N Abbaspour","year":"2014","unstructured":"Abbaspour N, Hurrell R, Kelishadi R (2014) Review on iron and its importance for human health. J Res Med Sci 19:164\u2013174","journal-title":"J Res Med Sci"},{"key":"9738_CR2","doi-asserted-by":"publisher","first-page":"a011312","DOI":"10.1101\/cshperspect.a011312","volume":"5","author":"O Stehling","year":"2013","unstructured":"Stehling O, Lill R (2013) The role of mitochondria in cellular Iron-sulfur protein biogenesis: mechanisms, connected processes, and diseases. Cold Spring Harb Perspect Biol 5:a011312\u2013a011312. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a011312","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9738_CR3","volume-title":"Co-morbidities in heart failure, an issue of heart failure clinics","author":"F Zannad","year":"2014","unstructured":"Zannad F (2014) Co-morbidities in heart failure, an issue of heart failure clinics. E-Book, Elsevier Health Sciences"},{"key":"9738_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ejhf.467","volume":"18","author":"M Stugiewicz","year":"2016","unstructured":"Stugiewicz M, Tkaczyszyn M, Kasztura M, Banasiak W, Ponikowski P, Jankowska EA (2016) The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications. Eur J Heart Fail 18:762\u2013773. \n                    https:\/\/doi.org\/10.1002\/ejhf.467","journal-title":"Eur J Heart Fail"},{"key":"9738_CR5","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","volume":"35","author":"EA Jankowska","year":"2014","unstructured":"Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Ole\u015bkowska-Florek W, Zymli\u0144ski R, Biegus J, Siwo\u0142owski P, Banasiak W, Anker SD, Filippatos G, Cleland JGF, Ponikowski P (2014) Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 35:2468\u20132476. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu235","journal-title":"Eur Heart J"},{"key":"9738_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","volume":"34","author":"EA Jankowska","year":"2013","unstructured":"Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P (2013) Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 34:816\u2013829. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehs224","journal-title":"Eur Heart J"},{"key":"9738_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA et al (2013) Iron deficiency in chronic heart failure: An international pooled analysis. Am Heart J 165:575\u2013582.e3. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2013.01.017","journal-title":"Am Heart J"},{"key":"9738_CR8","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","volume":"58","author":"DO Okonko","year":"2011","unstructured":"Okonko DO, Mandal AKJ, Missouris CG, Poole-Wilson PA (2011) Disordered Iron homeostasis in chronic heart failure. J Am Coll Cardiol 58:1241\u20131251. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.04.040","journal-title":"J Am Coll Cardiol"},{"key":"9738_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nrcardio.2011.77","volume":"8","author":"DJ Veldhuisen van","year":"2011","unstructured":"van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC (2011) Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol 8:485\u2013493. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2011.77","journal-title":"Nat Rev Cardiol"},{"key":"9738_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1017\/S1368980008002401","volume":"12","author":"E McLean","year":"2009","unstructured":"McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B (2009) Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993\u20132005. Public Health Nutr 12:444. \n                    https:\/\/doi.org\/10.1017\/S1368980008002401","journal-title":"Public Health Nutr"},{"key":"9738_CR11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/jn\/110.9.1754","volume":"110","author":"PR Flanagan","year":"1980","unstructured":"Flanagan PR, Haist J, Valberg LS (1980) Comparative effects of iron deficiency induced by bleeding and a low-iron diet on the intestinal absorptive interactions of iron, cobalt, manganese, zinc, lead and cadmium. J Nutr 110:1754\u20131763","journal-title":"J Nutr"},{"key":"9738_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/10715760802459879","volume":"42","author":"E Nagababu","year":"2008","unstructured":"Nagababu E, Gulyani S, Earley CJ, Cutler RG, Mattson MP, Rifkind JM (2008) Iron-deficiency anaemia enhances red blood cell oxidative stress. Free Radic Res 42:824\u2013829. \n                    https:\/\/doi.org\/10.1080\/10715760802459879","journal-title":"Free Radic Res"},{"key":"9738_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2016.03.039","volume":"212","author":"JE Toblli","year":"2016","unstructured":"Toblli JE, Cao G, Rivas C, Giani JF, Dominici FP (2016) Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative\/nitrosative stress and inflammation. Int J Cardiol 212:84\u201391. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.039","journal-title":"Int J Cardiol"},{"key":"9738_CR14","doi-asserted-by":"publisher","first-page":"H585","DOI":"10.1152\/ajpheart.00463.2008","volume":"296","author":"Y Naito","year":"2009","unstructured":"Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T (2009) Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 296:H585\u2013H593. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00463.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9738_CR15","unstructured":"Olivetti G, Quaini F, Lagrasta C, et al (1992) Myocyte Cellular Hypertrophy and Hyperplasia Contribute to Ventricular Wall Remodeling in Anemia-induced Cardiac Hypertrophy in Rats Am J Pathol 141:"},{"key":"9738_CR16","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/0006-2952(94)90303-4","volume":"47","author":"Z Tanne","year":"1994","unstructured":"Tanne Z, Coleman R, Nahir M, Shomrat D, Finberg JPM, Youdim MBH (1994) Ultrastructural and cytochemical changes in the heart of iron-deficient rats. Biochem Pharmacol 47:1759\u20131766. \n                    https:\/\/doi.org\/10.1016\/0006-2952(94)90303-4","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"9738_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3181\/00379727-218-44306","volume":"218","author":"DM Medeiros","year":"1998","unstructured":"Medeiros DM, Beard JL (1998) Dietary iron deficiency results in cardiac eccentric hypertrophy in rats. Proc Soc Exp Biol Med 218(4):370\u2013375","journal-title":"Proc Soc Exp Biol Med"},{"key":"9738_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jacc.2011.01.059","volume":"58","author":"MT Maeder","year":"2011","unstructured":"Maeder MT, Khammy O, dos Remedios C, Kaye DM (2011) Myocardial and systemic Iron depletion in heart failure: implications for Anemia accompanying heart failure. J Am Coll Cardiol 58:474\u2013480. \n                    https:\/\/doi.org\/10.1016\/J.JACC.2011.01.059","journal-title":"J Am Coll Cardiol"},{"key":"9738_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","volume":"138","author":"IS Anand","year":"2018","unstructured":"Anand IS, Gupta P (2018) Anemia and Iron deficiency in heart failure. Circulation 138:80\u201398. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.030099","journal-title":"Circulation"},{"key":"9738_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6793-2-1","volume":"2","author":"LR Turner","year":"2002","unstructured":"Turner LR, Premo DA, Gibbs BJ, Hearthway ML, Motsko M, Sappington A, Walker LA, Mullendore ME, Chew HG (2002) Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy. BMC Physiol 2:1","journal-title":"BMC Physiol"},{"key":"9738_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/01.CIR.39.4.503","volume":"39","author":"M Duke","year":"1969","unstructured":"Duke M, Abelmann WH (1969) The hemodynamic response to chronic anemia. Circulation 39:503\u2013515","journal-title":"Circulation"},{"key":"9738_CR22","unstructured":"Petering DH, Stemmer KL, Lyman S, et al (1990) Iron deficiency in growing male rats: a cause of development of cardiomyopathy. Ann Nutr Metab 34:(4)232\u2013243. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2400205\n                    \n                  . Accessed September 22, 2017"},{"key":"9738_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1042\/CS20040278","volume":"109","author":"F Dong","year":"2005","unstructured":"Dong F, Zhang X, Culver B, Chew HG Jr, Kelley RO, Ren J (2005) Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci 109:277\u2013286. \n                    https:\/\/doi.org\/10.1042\/CS20040278","journal-title":"Clin Sci"},{"key":"9738_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/cvr\/cvn280","volume":"81","author":"H Tsutsui","year":"2008","unstructured":"Tsutsui H, Kinugawa S, Matsushima S (2008) Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 81:449\u2013456. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvn280","journal-title":"Cardiovasc Res"},{"key":"9738_CR25","doi-asserted-by":"publisher","first-page":"24911","DOI":"10.1074\/jbc.C400051200","volume":"279","author":"A Nur-E-Kamal","year":"2004","unstructured":"Nur-E-Kamal A, Gross SR, Pan Z, Balklava Z, Ma J, Liu LF (2004) Nuclear translocation of cytochrome c during apoptosis. J Biol Chem 279:24911\u201324914. \n                    https:\/\/doi.org\/10.1074\/jbc.C400051200","journal-title":"J Biol Chem"},{"key":"9738_CR26","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1194\/jlr.M300140-JLR200","volume":"44","author":"P Gargalovic","year":"2003","unstructured":"Gargalovic P, Dory L (2003) Cellular apoptosis is associated with increased caveolin-1 expression in macrophages. J Lipid Res 44:1622\u20131632. \n                    https:\/\/doi.org\/10.1194\/jlr.M300140-JLR200","journal-title":"J Lipid Res"},{"issue":"5","key":"9738_CR27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/01.RES.39.5.744","volume":"39","author":"L Blayney","year":"1976","unstructured":"Blayney L, Bailey-Wood R, Jacobs A, Henderson A, Muir J (1976) The effects of iron deficiency on the respiratory function and cytochrome content of rat heart mitochondria. Circ Res 39(5):744\u2013748","journal-title":"Circ Res"},{"key":"9738_CR28","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1357-2725(99)00070-9","volume":"31","author":"P Ponka","year":"1999","unstructured":"Ponka P, Lok CN (1999) The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 31:1111\u20131137","journal-title":"Int J Biochem Cell Biol"},{"key":"9738_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","volume":"117","author":"MW Hentze","year":"2004","unstructured":"Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285\u2013297","journal-title":"Cell"},{"key":"9738_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/7727","volume":"21","author":"N Andrews","year":"1999","unstructured":"Andrews N, Levy JE, Jin O, Fujiwara Y, Kuo F (1999) Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 21:396\u2013399. \n                    https:\/\/doi.org\/10.1038\/7727","journal-title":"Nat Genet"},{"key":"9738_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","volume":"13","author":"W Xu","year":"2015","unstructured":"Xu W, Barrientos T, Mao L, Rockman HA, Sauve AA, Andrews NC (2015) Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Rep 13:533\u2013545. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2015.09.023","journal-title":"Cell Rep"},{"key":"9738_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2013.06.015","volume":"18","author":"O Stehling","year":"2013","unstructured":"Stehling O, Mascarenhas J, Vashisht AA, Sheftel AD, Niggemeyer B, R\u00f6sser R, Pierik AJ, Wohlschlegel JA, Lill R (2013) Human CIA2A-FAM96A and CIA2B-FAM96B integrate Iron homeostasis and maturation of different subsets of cytosolic-nuclear Iron-sulfur proteins. Cell Metab 18:187\u2013198. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2013.06.015","journal-title":"Cell Metab"},{"key":"9738_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cmet.2013.02.004","volume":"17","author":"W Xu","year":"2013","unstructured":"Xu W, Barrientos T, Andrews NC (2013) Iron and copper in mitochondrial diseases. Cell Metab 17:319\u2013328. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2013.02.004","journal-title":"Cell Metab"},{"key":"9738_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cmet.2005.02.005","volume":"1","author":"T Ganz","year":"2005","unstructured":"Ganz T (2005) Cellular iron: Ferroportin is the only way out. Cell Metab 1:155\u2013157. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2005.02.005","journal-title":"Cell Metab"},{"key":"9738_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng1053","volume":"33","author":"A Roetto","year":"2002","unstructured":"Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2002) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21\u201322. \n                    https:\/\/doi.org\/10.1038\/ng1053","journal-title":"Nat Genet"},{"key":"9738_CR36","doi-asserted-by":"publisher","unstructured":"Nemeth E, Tuttle MS, Powelson J et al (2004) Hepcidin regulates cellular Iron efflux by binding to Ferroportin and inducing its internalization. Science (80- ) 306:2090\u20132093. \n                    https:\/\/doi.org\/10.1126\/science.1104742","DOI":"10.1126\/science.1104742"},{"key":"9738_CR37","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1210\/en.2006-1331","volume":"148","author":"U Merle","year":"2007","unstructured":"Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H (2007) The Iron regulatory peptide Hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology 148:2663\u20132668. \n                    https:\/\/doi.org\/10.1210\/en.2006-1331","journal-title":"Endocrinology"},{"key":"9738_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1677\/joe.1.05729","volume":"184","author":"H Kulaksiz","year":"2005","unstructured":"Kulaksiz H, Theilig F, Bachmann S, Gehrke SG, Rost D, Janetzko A, Cetin Y, Stremmel W (2005) The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 184:361\u2013370. \n                    https:\/\/doi.org\/10.1677\/joe.1.05729","journal-title":"J Endocrinol"},{"key":"9738_CR39","doi-asserted-by":"publisher","first-page":"e89003","DOI":"10.1371\/journal.pone.0089003","volume":"9","author":"RC McCarthy","year":"2014","unstructured":"McCarthy RC, Kosman DJ (2014) Glial cell Ceruloplasmin and Hepcidin differentially regulate Iron efflux from brain microvascular endothelial cells. PLoS One 9:e89003. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0089003","journal-title":"PLoS One"},{"key":"9738_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/molehr\/gaq101","volume":"17","author":"P Evans","year":"2011","unstructured":"Evans P, Cindrova-Davies T, Muttukrishna S, Burton GJ, Porter J, Jauniaux E (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. Mol Hum Reprod 17:227\u2013232. \n                    https:\/\/doi.org\/10.1093\/molehr\/gaq101","journal-title":"Mol Hum Reprod"},{"key":"9738_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/labinvest.2017.111","volume":"98","author":"D Vela","year":"2017","unstructured":"Vela D (2017) Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology. Lab Investig 98:315\u2013326. \n                    https:\/\/doi.org\/10.1038\/labinvest.2017.111","journal-title":"Lab Investig"},{"key":"9738_CR42","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1073\/pnas.1422373112","volume":"112","author":"S Lakhal-Littleton","year":"2015","unstructured":"Lakhal-Littleton S, Wolna M, Carr CA, Miller JJJ, Christian HC, Ball V, Santos A, Diaz R, Biggs D, Stillion R, Holdship P, Larner F, Tyler DJ, Clarke K, Davies B, Robbins PA (2015) Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci 112:3164\u20133169. \n                    https:\/\/doi.org\/10.1073\/pnas.1422373112","journal-title":"Proc Natl Acad Sci"},{"key":"9738_CR43","doi-asserted-by":"publisher","unstructured":"Lakhal-Littleton S, Wolna M, Chung YJ, Christian HC, Heather LC, Brescia M, Ball V, Diaz R, Santos A, Biggs D, Clarke K, Davies B, Robbins PA (2016) An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. Elife 5. \n                    https:\/\/doi.org\/10.7554\/eLife.19804","DOI":"10.7554\/eLife.19804"},{"key":"9738_CR44","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2005-02-0561","volume":"106","author":"H Drakesmith","year":"2005","unstructured":"Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR (2005) Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106:1092\u20131097. \n                    https:\/\/doi.org\/10.1182\/blood-2005-02-0561","journal-title":"Blood"},{"key":"9738_CR45","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1182\/blood-2004-11-4502","volume":"105","author":"LM Schimanski","year":"2005","unstructured":"Schimanski LM, Drakesmith H, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR (2005) In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105:4096\u20134102. \n                    https:\/\/doi.org\/10.1182\/blood-2004-11-4502","journal-title":"Blood"},{"key":"9738_CR46","doi-asserted-by":"publisher","unstructured":"Anderson CP, Shen M,\u00a0Eisenstein RS,\u00a0Leiboldac EA \u00a0(2012) Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta - Mol Cell Res 1823:1468\u20131483. \n                    https:\/\/doi.org\/10.1016\/J.BBAMCR.2012.05.010","DOI":"10.1016\/J.BBAMCR.2012.05.010"},{"key":"9738_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: regulation of mammalian Iron metabolism. Cell 142:24\u201338. \n                    https:\/\/doi.org\/10.1016\/j.cell.2010.06.028","journal-title":"Cell"},{"key":"9738_CR48","doi-asserted-by":"publisher","first-page":"22846","DOI":"10.1074\/jbc.M111.231902","volume":"286","author":"A Sty\u015b","year":"2011","unstructured":"Sty\u015b A, Galy B, Starzy\u0144ski RR, Smuda E, Drapier JC, Lipi\u0144ski P, Bouton C (2011) Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide. J Biol Chem 286:22846\u201322854. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.231902","journal-title":"J Biol Chem"},{"key":"9738_CR49","doi-asserted-by":"publisher","unstructured":"Volz K (2008) The functional duality of iron regulatory protein 1. Curr Opin Struct Biol 18:106\u2013111. \n                    https:\/\/doi.org\/10.1016\/j.sbi.2007.12.010","DOI":"10.1016\/j.sbi.2007.12.010"},{"key":"9738_CR50","doi-asserted-by":"publisher","first-page":"ehw333","DOI":"10.1093\/eurheartj\/ehw333","volume":"38","author":"S Haddad","year":"2016","unstructured":"Haddad S, Wang Y, Galy B et al (2016) Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur heart J 38:ehw333. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw333","journal-title":"Eur heart J"},{"key":"9738_CR51","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","volume":"31","author":"EA Jankowska","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJV, Anker SD, Ponikowski P (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31:1872\u20131880. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehq158","journal-title":"Eur Heart J"},{"key":"9738_CR52","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ejhf.139","volume":"16","author":"A Cohen-Solal","year":"2014","unstructured":"Cohen-Solal A, Damy T, Terbah M, Kerebel S, Baguet JP, Hanon O, Zannad F, Laperche T, Leclercq C, Concas V, Duvilli\u00e9 L, Darn\u00e9 B, Anker S, Mebazaa A (2014) High prevalence of iron deficiency in patients with acute decompensated heart failure. Eur J Heart Fail 16:984\u2013991. \n                    https:\/\/doi.org\/10.1002\/ejhf.139","journal-title":"Eur J Heart Fail"},{"key":"9738_CR53","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/ejhf.513","volume":"18","author":"J N\u00fa\u00f1ez","year":"2016","unstructured":"N\u00fa\u00f1ez J, Com\u00edn-Colet J, Mi\u00f1ana G, N\u00fa\u00f1ez E, Santas E, Mollar A, Valero E, Garc\u00eda-Blas S, Cardells I, Bod\u00ed V, Chorro FJ, Sanchis J (2016) Iron deficiency and risk of early readmission following a hospitalization for acute heart failure. Eur J Heart Fail 18:798\u2013802. \n                    https:\/\/doi.org\/10.1002\/ejhf.513","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"9738_CR54","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ejhf.640","volume":"19","author":"V Melenovsky","year":"2017","unstructured":"Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H, Pluhacek T, Spatenka J, Kovalcikova J, Drahota Z, Kautzner J, Pirk J, Houstek J (2017) Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail 19(4):522\u2013530. \n                    https:\/\/doi.org\/10.1002\/ejhf.640","journal-title":"Eur J Heart Fail"},{"key":"9738_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","volume":"159","author":"P Leszek","year":"2012","unstructured":"Leszek P, Sochanowicz B, Szperl M, Kolsut P, Brz\u00f3ska K, Piotrowski W, Rywik TM, Danko B, Polkowska-Motrenko H, R\u00f3\u017ca\u0144ski JM, Kruszewski M (2012) Myocardial iron homeostasis in advanced chronic heart failure patients. Int J Cardiol 159:47\u201352. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2011.08.006","journal-title":"Int J Cardiol"},{"key":"9738_CR56","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ejhf.1154","volume":"20","author":"MF Hoes","year":"2018","unstructured":"Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG, Rodenburg RJ, van Veldhuisen DJ, de Boer RA, van der Meer P (2018) Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur J Heart Fail 20:910\u2013919. \n                    https:\/\/doi.org\/10.1002\/ejhf.1154","journal-title":"Eur J Heart Fail"},{"key":"9738_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5603\/KP.a2016.0155","volume":"75","author":"M Kasztura","year":"2017","unstructured":"Kasztura M, Dzi\u0119ga\u0142a M, Kobak K, Bania J, Mazur G, Banasiak W, Ponikowski P, Jankowska EA (2017) Both iron excess and iron depletion impair viability of rat H9C2 cardiomyocytes and L6G8C5 myocytes. Kardiol Pol 75:267\u2013275. \n                    https:\/\/doi.org\/10.5603\/KP.a2016.0155","journal-title":"Kardiol Pol"},{"key":"9738_CR58","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.3892\/mmr.2016.5705","volume":"14","author":"M Dziegala","year":"2016","unstructured":"Dziegala M, Kasztura M, Kobak K, Bania J, Banasiak W, Ponikowski P, Jankowska EA (2016) Influence of the availability of iron during hypoxia on the genes associated with apoptotic activity and local iron metabolism in rat H9C2 cardiomyocytes and L6G8C5 skeletal myocytes. Mol Med Rep 14:3969\u20133977. \n                    https:\/\/doi.org\/10.3892\/mmr.2016.5705","journal-title":"Mol Med Rep"},{"key":"9738_CR59","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.amjcard.2013.11.061","volume":"113","author":"M Nagao","year":"2014","unstructured":"Nagao M, Matsuo Y, Kamitani T, Yonezawa M, Yamasaki Y, Kawanami S, Abe K, Mukai Y, Higo T, Yabuuchi H, Takemura A, Yoshiura T, Sunagawa K, Honda H (2014) Quantification of myocardial Iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging. Am J Cardiol 113:1024\u20131030. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2013.11.061","journal-title":"Am J Cardiol"},{"key":"9738_CR60","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10554-014-0562-1","volume":"31","author":"M Nagao","year":"2015","unstructured":"Nagao M, Baba S, Yonezawa M, Yamasaki Y, Kamitani T, Isoda T, Kawanami S, Maruoka Y, Kitamura Y, Abe K, Higo T, Sunagawa K, Honda H (2015) Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2* MRI and MIBG scintigraphy. Int J Cardiovasc Imaging 31:399\u2013407. \n                    https:\/\/doi.org\/10.1007\/s10554-014-0562-1","journal-title":"Int J Cardiovasc Imaging"},{"key":"9738_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ehf2.12101","volume":"3","author":"J N\u00fa\u00f1ez","year":"2016","unstructured":"N\u00fa\u00f1ez J, Monmeneu JV, Mollar A, N\u00fa\u00f1ez E, Bod\u00ed V, Mi\u00f1ana G, Garc\u00eda-Blas S, Santas E, Ag\u00fcero J, Chorro FJ, Sanchis J, L\u00f3pez-Lereu MP (2016) Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study. ESC Hear Fail 3:293\u2013298. \n                    https:\/\/doi.org\/10.1002\/ehf2.12101","journal-title":"ESC Hear Fail"},{"key":"9738_CR62","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.jacc.2012.05.065","volume":"60","author":"JV Terrovitis","year":"2012","unstructured":"Terrovitis JV, Kaldara E, Ntalianis A, Sventzouri S, Kapelios C, Barbarousi D, Matsouka C, Nanas JN (2012) Intravenous Iron alone is equally effective with the combination of Iron and erythropoietin for the treatment of Iron-deficiency Anemia in advanced heart failure. J Am Coll Cardiol 60:2255\u20132256. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.05.065","journal-title":"J Am Coll Cardiol"},{"key":"9738_CR63","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ejhf.236","volume":"17","author":"T McDonagh","year":"2015","unstructured":"McDonagh T, Macdougall IC (2015) Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? Eur J Heart Fail 17:248\u2013262. \n                    https:\/\/doi.org\/10.1002\/ejhf.236","journal-title":"Eur J Heart Fail"},{"key":"9738_CR64","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, Tang WHW, LaRue SJ, Redfield MM, Semigran MJ, Givertz MM, van Buren P, Whellan D, Anstrom KJ, Shah MR, Desvigne-Nickens P, Butler J, Braunwald E, for the NHLBI Heart Failure Clinical Research Network (2017) Effect of Oral Iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and Iron deficiency. JAMA 317:1958\u20131966. \n                    https:\/\/doi.org\/10.1001\/jama.2017.5427","journal-title":"JAMA"},{"key":"9738_CR65","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, L\u00fcscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators (2009) Ferric Carboxymaltose in patients with heart failure and Iron deficiency. N Engl J Med 361:2436\u20132448. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"key":"9738_CR66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD, for the CONFIRM-HF Investigators (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 36:657\u2013668. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu385","journal-title":"Eur Heart J"},{"key":"9738_CR67","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/eurjhf\/hft099","volume":"15","author":"G Filippatos","year":"2013","unstructured":"Filippatos G, Farmakis D, Colet JC, Dickstein K, L\u00fcscher TF, Willenheimer R, Parissis J, Gaudesius G, Mori C, von Eisenhart Rothe B, Greenlaw N, Ford I, Ponikowski P, Anker SD (2013) Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. Eur J Heart Fail 15:1267\u20131276. \n                    https:\/\/doi.org\/10.1093\/eurjhf\/hft099","journal-title":"Eur J Heart Fail"},{"key":"9738_CR68","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","volume":"48","author":"AP Bolger","year":"2006","unstructured":"Bolger AP, Bartlett FR, Penston HS, O\u2019Leary J, Pollock N, Kaprielian R, Chapman CM (2006) Intravenous Iron alone for the treatment of Anemia in patients with chronic heart failure. J Am Coll Cardiol 48:1225\u20131227. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2006.07.015","journal-title":"J Am Coll Cardiol"},{"key":"9738_CR69","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","volume":"50","author":"JE Toblli","year":"2007","unstructured":"Toblli JE, Lombra\u00f1a A, Duarte P, Di Gennaro F (2007) Intravenous Iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 50:1657\u20131665. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2007.07.029","journal-title":"J Am Coll Cardiol"},{"key":"9738_CR70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","volume":"51","author":"DO Okonko","year":"2008","unstructured":"Okonko DO, Grzeslo A, Witkowski T, Mandal AKJ, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P (2008) Effect of intravenous Iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and Iron deficiency. J Am Coll Cardiol 51:103\u2013112. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2007.09.036","journal-title":"J Am Coll Cardiol"},{"key":"9738_CR71","unstructured":"Usmanov RI, Zueva EB, Silverberg DS, Shaked M Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol 21:236\u2013242"},{"key":"9738_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1540-8175.2011.01532.x","volume":"29","author":"R Gaber","year":"2012","unstructured":"Gaber R, Kotb NA, Ghazy M, Nagy HM, Salama M, Elhendy A (2012) Tissue Doppler and strain rate imaging detect improvement of myocardial function in Iron deficient patients with congestive heart failure after Iron replacement therapy. Echocardiography 29:13\u201318. \n                    https:\/\/doi.org\/10.1111\/j.1540-8175.2011.01532.x","journal-title":"Echocardiography"},{"key":"9738_CR73","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jcp.10284","volume":"196","author":"Y Ke","year":"2003","unstructured":"Ke Y, Chen YY, Chang YZ, Duan XL, Ho KP, Jiang DH, Wang K, Qian ZM (2003) Post-transcriptional expression of DMT1 in the heart of rat. J Cell Physiol 196:124\u2013130. \n                    https:\/\/doi.org\/10.1002\/jcp.10284","journal-title":"J Cell Physiol"},{"key":"9738_CR74","doi-asserted-by":"publisher","first-page":"ehw386","DOI":"10.1093\/eurheartj\/ehw386","volume":"38","author":"P Zhabyeyev","year":"2016","unstructured":"Zhabyeyev P, Oudit GY (2016) Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure. Eur heart J 38:ehw386. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw386","journal-title":"Eur heart J"},{"key":"9738_CR75","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129\u20132200. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-018-9738-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-018-9738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-018-9738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T19:25:58Z","timestamp":1570044358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-018-9738-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["9738"],"URL":"https:\/\/doi.org\/10.1007\/s10741-018-9738-4","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"3 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wroc\u0142aw Medical University received an unrestricted grant from Vifor Pharma outside the submitted work. Monika Kasztura reports financial support from Vifor Pharma for travel and accommodation for scientific meeting. Waldemar Banasiak reports personal fees from Vifor Pharma, outside the submitted work. Piotr Ponikowski reports personal fees from Vifor Pharma and personal fees from AMGEN, outside the submitted work. Ewa A. Jankowska reports personal fees from Vifor Pharma and FRESENIUS, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}